Evidence map›Paper›PMID 22549242›Full record

ArticlePflugers Archiv : European journal of physiology2012

Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway.

Nils van der Lubbe, Christina H Lim, Marcel E Meima, Richard van Veghel, Lena Lindtoft Rosenbaek, Kerim Mutig, Alexander H J Danser, Robert A Fenton, Robert Zietse, Ewout J Hoorn

Abstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Review
  2. SECS, drugs, and Rac1&Rho: regulation of EnNaC in vascular endothelial cells.Pflugers Archiv : European journal of physiology · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Responses of distal nephron NaAmerican journal of physiology. Renal physiology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nils van der LubbeDepartment of Internal Medicine, Erasmus Medical Center, PO Box 2040, Room D-405, 3000 CA, Rotterdam, The Netherlands.
Christina H Lim
Marcel E Meima
Richard van Veghel
Lena Lindtoft Rosenbaek
Kerim Mutig
Alexander H J Danser
Robert A Fenton
Robert Zietse
Ewout J Hoorn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We and others have recently shown that angiotensin II can activate the sodium chloride cotransporter (NCC) through a WNK4-SPAK-dependent pathway. Because WNK4 was previously shown to be a negative regulator of NCC, it has been postulated that angiotensin II converts WNK4 to a positive regulator. Here, we ask whether aldosterone requires angiotensin II to activate NCC and if their effects are additive. To do so, we infused vehicle or aldosterone in adrenalectomized rats that also received the angiotensin receptor blocker losartan. In the presence of losartan, aldosterone was still capable of increasing total and phosphorylated NCC twofold to threefold. The kinases WNK4 and SPAK also increased with aldosterone and losartan. A dose-dependent relationship between aldosterone and NCC, SPAK, and WNK4 was identified, suggesting that these are aldosterone-sensitive proteins. As more functional evidence of increased NCC activity, we showed that rats receiving aldosterone and losartan had a significantly greater natriuretic response to hydrochlorothiazide than rats receiving losartan only. To study whether angiotensin II could have an additive effect, rats receiving aldosterone with losartan were compared with rats receiving aldosterone only. Rats receiving aldosterone only retained more sodium and had twofold to fourfold increase in phosphorylated NCC. Together, our results demonstrate that aldosterone does not require angiotensin II to activate NCC and that WNK4 appears to act as a positive regulator in this pathway. The additive effect of angiotensin II may favor electroneutral sodium reabsorption during hypovolemia and may contribute to hypertension in diseases with an activated renin-angiotensin-aldosterone system.

Indexed as

AdrenalectomyAldosteroneAmilorideAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsDiureticsDose-Response Relationship, DrugHydrochlorothiazideKidneyLosartanModels, AnimalProtein Serine-Threonine KinasesRatsRats, Sprague-DawleySignal TransductionAldosteroneAmilorideAngiotensin IIAngiotensin II Type 1 Receptor BlockersDiureticsHydrochlorothiazideLosartanPAS domain kinasesProtein Serine-Threonine KinasesSodium Chloride SymportersWnk4 protein, rat

Identifiers

PMID22549242
PMCPMC3350624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.